29th Mar 2022

Interim results to 31 December 2021

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...

29th Mar 2022

NICE issues Medtech Innovation Briefing on Genedrive ® MT-RNR1 Tes

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...

21st Mar 2022

PALOH study results published in JAMA Pediatrics

Publication confirms Genedrive® MT-RNR1 test’s role in avoiding antibiotic related hearing l...